The apatite formation ability of CaF2 doping tricalcium silicates in simulated body fluid

被引:22
作者
Lin, Qing [1 ]
Li, Yanbao [1 ]
Lan, Xianghui [1 ]
Lu, Chunhua [1 ]
Chen, Yixin [2 ]
Xu, Zhongzi [1 ]
机构
[1] Nanjing Univ Technol, Coll Mat Sci & Engn, State Key Lab Mat Oriented Chem Engn, Nanjing 210009, Peoples R China
[2] Nanjing Univ, Sch Med, Drum Tower Hosp Nanjing, Dept Orthopaed, Nanjing 210093, Peoples R China
关键词
IN-VITRO BIOACTIVITY; GROWTH; MECHANISM; PHOSPHATE; FLUORIDE; ALUMINUM; CEMENT; GLASS;
D O I
10.1088/1748-6041/4/4/045005
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The purpose of this study was to investigate the effects of CaF2 on the apatite formation ability of tricalcium silicates (Ca3SiO5, C3S) and the mechanism of apatite formation on C3S pastes. Different amounts of CaF2 (0, 1, 2 and 3 wt%) were mixed in the raw materials during the synthesis process of C3S. The apatite formation ability of the CaF2 doping C3S was examined by soaking the one-day setting pastes in simulated body fluid (SBF). The fluoride concentrations, pH values, structural and morphological variations of the pastes were examined during soaking in SBF. With the addition of CaF2, the initial crystalline apatite formation time of the pastes was decreased from three days to one day. After soaking for seven days, the thicknesses of apatite layers depositing on the surface of C3S doped with 0, 1, 2 and 3 wt% CaF2 were about 88, 102, 168 and 136 mu m, respectively. C3S doped with 2 wt% CaF2 showed the better ability to induce the formation of apatite. Furthermore, the mechanism of the apatite formation of the CaF2 doping C3S pastes may be attributed to the formation and stability of F-substituted apatite determined by x-ray photoelectron spectroscopy (XPS) at the early age. The results indicated that CaF2 doping C3S has better in vitro bioactivity, and may be used to prepare novel bone cement.
引用
收藏
页数:6
相关论文
共 25 条
[1]   Effect of CaF2 and MgO on sintering of cement clinker [J].
Altun, IA .
CEMENT AND CONCRETE RESEARCH, 1999, 29 (11) :1847-1850
[2]   The F content in sol-gel derived FHA coatings: an XPS study [J].
Cheng, K ;
Zhang, S ;
Weng, WJ .
SURFACE & COATINGS TECHNOLOGY, 2005, 198 (1-3) :237-241
[3]   A preliminary investigation of the in vitro bioactivity of white Portland cement [J].
Coleman, N. J. ;
Nicholson, J. W. ;
Awosanya, K. .
CEMENT AND CONCRETE RESEARCH, 2007, 37 (11) :1518-1523
[5]  
Hayakawa S, 1999, J AM CERAM SOC, V82, P2155
[6]   Genetic design of bioactive glass [J].
Hench, Larry L. .
JOURNAL OF THE EUROPEAN CERAMIC SOCIETY, 2009, 29 (07) :1257-1265
[7]  
Hench LL, 1998, J AM CERAM SOC, V81, P1705
[8]   Novel tricalcium silicate/monocalcium phosphate monohydrate composite bone cement [J].
Huan, Zhiguang ;
Chang, Jiang .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2007, 82B (02) :352-359
[9]   Control of apatite crystal growth in a fluoride containing amelogenin-rich matrix [J].
Iijima, M ;
Moradian-Oldak, J .
BIOMATERIALS, 2005, 26 (13) :1595-1603
[10]   How useful is SBF in predicting in vivo bone bioactivity? [J].
Kokubo, T ;
Takadama, H .
BIOMATERIALS, 2006, 27 (15) :2907-2915